Giovanni Nigita

The Ohio State University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index2.7kcitations159works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(65), RNA modifications and cancer(65), Cancer-related molecular mechanisms research(42), Circular RNAs in diseases(30), RNA regulation and disease(21)

Publications159 total

Improving mortality prediction in critically ill cancer patients with a multidimensional machine learning model
2026Open Access
Oncogenic Driver Persistence in Liquid Biopsies As Predictor Outcomes in TKI Treated Non-Small Cell Lung Cancer
The Journal of Liquid Biopsy·2025Open Access
Longitudinal Monitoring of ctDNA Tumor Fraction Dynamics for Early Detection of Chemotherapy Resistance
The Journal of Liquid Biopsy·2025Open Access
Extent of ctDNA Tumor Fraction Reduction as a Predictor of Chemotherapy Outcomes in Advanced Solid Tumors
The Journal of Liquid Biopsy·2025Open Access
PT2.10.01 Incidence and Severity of Interstitial Lung Disease Associated With Antibody-Drug Conjugates in NSCLC and SCLC: A Meta-Analysis
Journal of Thoracic Oncology·2025
Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of <i>KEAP1</i>, <i>SMARCA4</i>, and <i>PTEN</i> mutations
Journal for ImmunoTherapy of Cancer·2025· 9 citedOpen Access
Protocol for analyzing tRNA-derived ncRNAs from small RNA-seq data using tRFUniverse functional analyses
STAR Protocols·2025Open Access
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
The Journal of Liquid Biopsy·2025· 17 citedOpen Access
Pleural Fluid Extracellular Vesicle MicroRNA as a Prognostic Indicator in Malignant Pleural Effusion
American Journal of Respiratory and Critical Care Medicine·2025
Pleural Fluid Extracellular microRNA-141-3p Can Differentiate Cytology-negative Malignant From Non-malignant Pleural Effusion
American Journal of Respiratory and Critical Care Medicine·2025
Abstract LB264: Evaluating TRAP1 as a novel, potential therapeutic target in dedifferentiated liposarcoma
Cancer Research·2025
ncRNA Editing: Functional Characterization and Computational Resources
Methods in molecular biology·2024
Oncogenic Functions of Alternatively Spliced MDM2-ALT2 Isoform in Retroperitoneal Liposarcoma
International Journal of Molecular Sciences·2024· 2 citedOpen Access
Abstract A054: Oncogenic functions of alternatively spliced <i>MDM2-ALT2</i> isoform in retroperitoneal liposarcoma
Clinical Cancer Research·2024
METTL3 alters capping enzyme expression and its activity on ribosomal proteins
Scientific Reports·2024· 4 citedOpen Access
895 Immunomodulatory role of CD74 in low-grade glioma bone marrow-derived myeloid cells
Regular and Young Investigator Award Abstracts·2024Open Access
KDM2B is required for ribosome biogenesis and its depletion unequally affects mRNA translation
2024· 2 citedOpen Access
Extracellular Vesicle—MDM2-DNA as a Potential Liquid Biopsy Biomarker for Disease Identification in Retroperitoneal Liposarcoma
Annals of Surgery·2024· 5 cited
Extracellular Vesicle MicroRNAs Can Differentiate Between Malignant and Non-malignant Pleural Effusion
2024
Poly(A)-specific RNase (PARN) generates and regulates miR-125a-5p 3’-isoforms, displaying an altered expression in breast cancer
Signal Transduction and Targeted Therapy·2024· 6 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Carlo M. Croce(33), Dario Veneziano(18), Rosario Distefano(18), Mario Acunzo(18), Giulia Romano(16), Federica Calore(11), Alfredo Ferro(9), Patrick Nana‐Sinkam(9), Luisa Tomasello(8), Alessandro Laganà(7), Pierluigi Gasparini(7), Gioacchino P. Marceca(7), Patricia Le(7), Alfredo Pulvirenti(6), Francesca Lovat(6), Paolo Fadda(6), Michela Saviana(6), Veronica Balatti(5), Alexey Palamarchuk(5), Matteo Fassan(5)